Surrogate endpoints: A basis for a rational approach
- 1 September 1992
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 43 (3), 235-244
- https://doi.org/10.1007/bf02333016
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- The Cardiac Arrhythmia Suppression Trial (CAST)New England Journal of Medicine, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Surrogate endpoints in clinical trials: Cardiovascular diseasesStatistics in Medicine, 1989
- Surrogate endpoints in clinical trials: CancerStatistics in Medicine, 1989
- The use of surrogate endpoints in clinical trials (an introduction to a series of four papers)Statistics in Medicine, 1989
- Surrogate endpoints in clinical trials: Ophthalmologic disordersStatistics in Medicine, 1989
- Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling projectJournal of Chronic Diseases, 1978
- Systolic versus diastolic blood pressure and risk of coronary heart diseaseThe American Journal of Cardiology, 1971